(99m)Tc-HisoDGR as a Potential SPECT Probe for Orthotopic Glioma Detection via Targeting of Integrin α5β1.
暂无分享,去创建一个
Fan Wang | Jiyun Shi | Bing Jia | Haitao Zhao | Xujie Liu | Hannan Gao | Luoping Zhai
[1] H. Kessler,et al. Complementary, Selective PET Imaging of Integrin Subtypes α5β1 and αvβ3 Using 68Ga-Aquibeprin and 68Ga-Avebetrin , 2016, The Journal of Nuclear Medicine.
[2] M. Schwaiger,et al. In vivo biokinetic and metabolic characterization of the 68Ga-labelled α5β1-selective peptidomimetic FR366 , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[3] Laura A. Sordillo,et al. Curcumin for the Treatment of Glioblastoma. , 2015, Anticancer research.
[4] Ming-Rong Zhang,et al. Development of the Fibronectin-Mimetic Peptide KSSPHSRN(SG)5RGDSP as a Novel Radioprobe for Molecular Imaging of the Cancer Biomarker α5β1 Integrin. , 2015, Biological & pharmaceutical bulletin.
[5] R. Christopherson,et al. Membrane Proteome Analysis of Glioblastoma Cell Invasion , 2015, Journal of neuropathology and experimental neurology.
[6] J. Groot. High-grade Gliomas , 2015 .
[7] I. Eder,et al. H-CRRETAWAC-OH, a Lead Structure for the Development of Radiotracer Targeting Integrin α 5 β 1? , 2014, BioMed research international.
[8] D. Rognan,et al. Single cell tracking assay reveals an opposite effect of selective small non-peptidic α5β1 or αvβ3/β5 integrin antagonists in U87MG glioma cells. , 2014, Biochimica et biophysica acta.
[9] J. Zhang,et al. Increased expression of α5β1-integrin is a prognostic marker for patients with gastric cancer , 2014, Clinical and Translational Oncology.
[10] M. Schwaiger,et al. Selective imaging of the angiogenic relevant integrins α5β1 and αvβ3. , 2013, Angewandte Chemie.
[11] H. Kessler,et al. Tumor Targeting via Integrin Ligands , 2013, Front. Oncol..
[12] R. Longhi,et al. IsoDGR-tagged albumin: a new αvβ3 selective carrier for nanodrug delivery to tumors. , 2013, Small.
[13] M. Civera,et al. Cyclic isoDGR peptidomimetics as low-nanomolar αvβ3 integrin ligands. , 2013, Chemistry.
[14] E. Novellino,et al. Biselectivity of isoDGR peptides for fibronectin binding integrin subtypes α5β1 and αvβ6: conformational control through flanking amino acids. , 2013, Journal of medicinal chemistry.
[15] M. Dontenwill,et al. Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors , 2013, Cancers.
[16] Hong Wang,et al. Prognostic significance of α5β1-integrin expression in cervical cancer. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[17] Z. Rao,et al. Clinicopathological and prognostic significance of α5β1-integrin and MMP-14 expressions in colorectal cancer. , 2013, Neoplasma.
[18] J. Godet,et al. Integrin α5β1 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high-grade glioma. , 2012, Cancer research.
[19] Fan Wang,et al. 99mTc-3PRGD2 for Integrin Receptor Imaging of Lung Cancer: A Multicenter Study , 2012, The Journal of Nuclear Medicine.
[20] Xiaona Jin,et al. Blood Clearance Kinetics, Biodistribution, and Radiation Dosimetry of a Kit-Formulated Integrin αvβ3-Selective Radiotracer 99mTc-3PRGD2 in Non-Human Primates , 2011, Molecular Imaging and Biology.
[21] E. Novellino,et al. Conformational control of integrin-subtype selectivity in isoDGR peptide motifs: a biological switch. , 2010, Angewandte Chemie.
[22] G. Pathuri,et al. Synthesis and in vivo evaluation of Tc-99m-labeled cyclic CisoDGRC peptide conjugates for targeting αvβ3 integrin expression. , 2010, Bioorganic & medicinal chemistry letters.
[23] K. Takeda,et al. α5β1 integrin antagonists reduce chemotherapy‐induced premature senescence and facilitate apoptosis in human glioblastoma cells , 2010, International journal of cancer.
[24] A. Griffioen,et al. Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer , 2010, Molecular Cancer.
[25] R. Longhi,et al. Structural Basis for the Interaction of isoDGR with the RGD-binding Site of αvβ3 Integrin* , 2008, Journal of Biological Chemistry.
[26] H. Kessler,et al. Rational Design of Highly Active and Selective Ligands for the α5β1 Integrin Receptor , 2008, Chembiochem : a European journal of chemical biology.
[27] Xiaoyuan Chen,et al. 99mTc-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancer. , 2008, Bioconjugate chemistry.
[28] H. Kessler,et al. Rationales Design von hoch aktiven und selektiven Liganden für α5β1‐ und αvβ3‐Integrine , 2007 .
[29] H. Jin,et al. Integrins: roles in cancer development and as treatment targets , 2004, British Journal of Cancer.
[30] W. Diluzio,et al. Towards developing a non-SnCl2 formulation for RP444, a new radiopharmaceutical for thrombus imaging. , 2001, Journal of pharmaceutical sciences.
[31] E Ruoslahti,et al. Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library , 1994, The Journal of cell biology.
[32] E. Ruoslahti,et al. Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library. , 1993, The Journal of biological chemistry.